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Abstract
Background: Williams-Beuren Syndrome (WBS) is a genetic disorder associated with multisystemic abnormalities,
including craniofacial dysmorphology and cognitive defects. It is caused by a hemizygous microdeletion involving
up to 28 genes in chromosome 7q11.23. Genotype/phenotype analysis of atypical microdeletions implicates two
evolutionary-related transcription factors, GTF2I and GTF2IRD1, as prime candidates for the cause of the facial
dysmorphology.
Results: Using a targeted Gtf2ird1 knockout mouse, we employed massively-parallel sequencing of mRNA
(RNA-Seq) to understand changes in the transcriptional landscape associated with inactivation of Gtf2ird1 in lip
tissue. We found widespread dysregulation of genes including differential expression of 78 transcription factors or
coactivators, several involved in organ development including Hey1, Myf6, Myog, Dlx2, Gli1, Gli2, Lhx2, Pou3f3, Sox2,
Foxp3. We also found that the absence of GTF2IRD1 is associated with increased expression of genes involved in
cellular proliferation, including growth factors consistent with the observed phenotype of extreme thickening of the
epidermis. At the same time, there was a decrease in the expression of genes involved in other signalling
mechanisms, including the Wnt pathway, indicating dysregulation in the complex networks necessary for epidermal
differentiation and facial skin patterning. Several of the differentially expressed genes have known roles in both
tissue development and neurological function, such as the transcription factor Lhx2 which regulates several genes
involved in both skin and brain development.
Conclusions: Gtf2ird1 inactivation results in widespread gene dysregulation, some of which may be due to the
secondary consequences of gene regulatory network disruptions involving several transcription factors and
signalling molecules. Genes involved in growth factor signalling and cell cycle progression were identified as
particularly important for explaining the skin dysmorphology observed in this mouse model. We have noted that a
number of the dysregulated genes have known roles in brain development as well as epidermal differentiation and
maintenance. Therefore, this study provides clues as to the underlying mechanisms that may be involved in the
broader profile of WBS.
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Background
Gtf2ird1 is a member of the Gtf2i family of genes, en-
coding a set of multifunctional transcription factors. The
three members of this family cluster within a domain of
the 7q11.23 chromosomal region that is prone to copy
number variation through non-allelic homologous re-
combination. Hemizygous deletion of this domain leads
to the neurodevelopmental disorder, Williams-Beuren
Syndrome (WBS) [1]. This is a multisystem disorder
with physical, cognitive and behavioural components.
Studies of WBS patients with atypical deletions of the
region have led to the conclusion that loss of GTF2IRD1
and GTF2I explain prominent features of the condition
such as the craniofacial dysmorphology, the intellectual
disability and the behavioural effects [2].
Analysis of mouse knockouts of the orthologous genes
Gtf2ird1 and Gtf2i support these conclusions. Homozy-
gous loss of Gtf2i causes embryonic lethality [3] but het-
erozygous loss results in increased anxiety, as measured
by the light–dark box and elevated plus maze tests [4].
Homozygous Gtf2ird1 mutants show reduced levels of ag-
gression in the resident intruder test [5] impaired motor
coordination and exploratory behaviour [6, 7] and altered
vocalization in response to specific stress-inducing cues
[6]. Homozygous loss of Gtf2ird1 has also been shown to
cause craniofacial abnormalities that in a transgene inser-
tion mutant, affects the alignment of the jaws [8], but in
the knockout model presented in this work, is mainly con-
fined to an excessive overgrowth of the soft tissue [6]. This
phenotype is not apparent in the heterozygous Gtf2ird1
knockout mice. Detailed analysis of adult homozygous
null Gtf2ird1tm1Hrd mice demonstrated that these abnor-
malities were confined to the regions around the lips and
the nose and histological sections showed that the in-
creased thickness was due to an enlargement of the epi-
dermal layer that sometimes resulted in skin flaps and
folds in the lips and around the nares [6]. While no hist-
ology of the face is available from WBS patients, it has
been noted that the majority of the WBS craniofacial
phenotype is soft tissue related [6].
Gtf2ird1 expression in the mouse is consistent with a
role in craniofacial development and brain function [9].
The Gtf2ird1 transcript is detectable from early stages of
embryogenesis through to the development of specific
tissues including cartilage, muscle, heart, brain and tooth
buds. In the developing head, many of the hard and soft
tissue components express Gtf2ird1. In the transition to
maturity, many of these sites are shut down and expres-
sion in the adult becomes mainly confined to sensory or-
gans, neurons of the peripheral and central nervous
system, smooth muscle, cardiac muscle, cells in the testis
and brown adipose tissue [9, 10].
Several studies illustrate GTF2IRD1’s DNA binding
properties [11, 12] and its ability to act as a transcriptional
regulator in transgenic mouse systems [13], as well as a
capacity to auto-regulate its own transcription through dir-
ect binding of the GTF2IRD1 protein to its own promoter
region [14]. However, much of the information regarding
GTF2IRD1 gene targets remains unknown. Analyses of
Gtf2ird1 knockout brain tissue, for example, have led to a
disappointing lack of useful information [15]. Other studies
have examined gene expression differences in mouse
embryonic fibroblasts (MEFs) that overexpress Gtf2ird1
[16, 17] and in a Gtf2ird1 gene-trap mutant mouse model
[3] that shows phenotypic defects that are more extreme
than the Gtf2ird1 deletion models [5, 6, 8, 14]. This is the
first published report of a comprehensive RNA-Seq ana-
lysis of the transcriptome of mice deficient for Gtf2ird1.
In this study we have analysed lip tissue from a
Gtf2ird1 knockout mouse model in order to capture ef-
fects that are most apparent in the epidermis. Our ob-
servation that certain dysregulated genes have roles both
in skin and brain development suggests that this analysis
can provide insight into molecular effectors and path-
ways involved in WBS.
Results
RNA-Seq analysis shows widespread gene dysregulation
in the Gtf2ird1 KO
RNA was extracted from mouse lip tissue of three fe-
male Gtf2ird1 knockout mice (KO) and three female
wild type mice (WT). The KO mice had a distinct phys-
ical appearance with overgrowth and wrinkling of the lip
tissue, consistent with the phenotype previously de-
scribed [6]. The six RNA-Seq libraries were sequenced
on the Illumina HiSeq2000 platform to produce over 60
million, 100 nucleotide paired-end reads per sample.
Differential expression analysis was performed using the
Bioconductor packages, edgeR [18] and subsequently
confirmed using DESeq2 [19], as detailed in Methods. In
this paper, we describe the RNA-Seq results broadly and
identify differentially expressed genes with roles in nor-
mal epidermal and neurological development.
Differential gene expression seen in both directions in
the Gtf2ird1 KO
Differential expression analysis of the KO and WT lip
tissue with edgeR identified 1165 genes with significantly
increased expression and 1073 genes with significantly
decreased expression (edgeR, FDR = 0.05) (Fig. 1a, b).
We found a large overlap in genes called as differentially
expressed using edgeR [18] and DESeq2 [19] of all the
genes found by either method, 73 % were common to
both methods (Fig. 1a, b). The WT and KO conditions
could be clearly distinguished using the multidimen-
sional scaling (MDS) plot (Fig. 1c). The clear separation
of the two genotypes was also evident in the heatmap
showing the expression level of the top 500 differentially
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expressed genes (Fig. 1d). Although a similar total num-
ber of up-regulated and down-regulated genes were
identified, when ordered by statistical significance (low-
est FDR values) we found that the most statistically sig-
nificant differentially expressed genes in the KO are up-
regulated as depicted in the heatmap (Fig. 1d). The lists
of up-regulated and down-regulated genes found using
edgeR were sorted by statistical significance (lowest
FDR) and the top 50 in the up-regulated and down-
regulated groups are listed in Table 1. Details of the
differentially expressed genes can be found in Additional
file 1: Table S1.
The genes listed in Table 1 have functions in transcrip-
tion regulation (Foxq1, Sebox, Csrp3, Vgll2, Zbtb16,
Sp110), signalling (Wnt7, Chrm3, P2ry4, Arhgap8,
Au021092, Lypd6, F3, Skint10, Tac4, Gfra2, Dcc, Lrrn4,
Defb13, Tie1, Ush2a), calcium binding (Pdlim3, Acsm1,
Alox15, Cacng1, Capn9, Csrp3, Cyp2f2, Gm1110,
Zbtb16), membrane transport (Slc6a19, Slc46a1, Aqp9),
apoptosis (Csrp3, Zbtb16, Sp110, Dcc, Actc1), neuro-
logical processes (Chrm3, Dcc, Gfra2, Slc6a19, Ush2a)
and development and maintenance of the stratified
epidermis (Aqp9, Krt2).
Several transcription factors identified in the differentially
expressed genes
Of the genes dysregulated by the inactivation of Gtf2ird1,
79 are transcription factors or cofactors (Table 2), identi-
fied using MetaCore™. Gene ontology analysis of this
group of genes performed using BiNGO reveals involve-
ment in organ/tissue development (46/79), embryonic
development (29/79), cell differentiation (39/79), regula-
tion of cell proliferation (14/79) and signalling through a
number of different pathways (26/79). Full details of the
Fig. 1 Differential expression analysis. a, b Venn diagrams of the sets of differentially expressed genes (DEGs) generated using different methods for
analyzing differential expression. a Genes up-regulated in KO, and (b) genes down-regulated in KO found using edgeR and DESeq2. c Multidimensional
scaling (MDS) plot generated using edgeR showing clustering of samples with the 3 biological replicates of WT (black) and 3 biological replicates of
KO (orange). d Heatmap generated using heatmap.2 function of the gplots package in R of the top 500 differentially expressed genes found using
edgeR, with input being the logCPM values for these genes. Blue represents lower expression, red represents higher expression
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Table 1 Top 50 up-regulated and down-regulated genes found using edgeR
Up-regulated genes logFCa FDRb Down-regulated genes logFCa FDRb
Slc14a2 8.39 5.0E-117 Krt2 −4.52 1.7E-57
Gm16026 10.57 8.7E-111 Acsm1 −3.35 8.8E-13
Lrrn4 9.33 8.7E-111 1100001G20Rik −2.54 1.6E-12
Cml2 9.16 4.6E-94 F3 −1.51 2.1E-12
Sp110 7.82 7.4E-90 Tac4 −1.79 7.0E-12
Gm15753 8.36 4.0E-87 Cyp2w1 −2.50 9.6E-12
Prr18 6.13 1.4E-75 Cacng1 −1.86 6.5E-10
C130026I21Rik 9.14 2.0E-75 Ces2f −1.99 4.8E-09
Echdc3 4.48 2.0E-66 Paqr5 −1.34 6.3E-09
AI427809 5.10 6.2E-61 Cyp2f2 −2.11 6.9E-09
Dhtkd1 4.31 2.0E-58 Gm1110 −2.87 5.0E-08
Gm7029 10.86 3.0E-58 Sebox −2.09 9.8E-08
Gm5335 9.11 3.2E-58 Wnt7b −1.36 1.0E-07
Ccdc60 6.30 1.5E-56 Gm26888 −2.27 2.0E-07
Apol7b 7.45 3.1E-55 Slc6a19 −1.26 2.5E-07
0610040J01Rik 4.75 5.3E-53 Ucp3 −1.67 5.0E-07
Ccser1 5.02 2.7E-52 Capn9 −2.16 9.9E-07
Gm8674 9.03 9.9E-51 Actc1 −1.74 1.5E-06
Fbxo16 5.43 1.6E-50 H19 −1.39 1.5E-06
BB557941 8.95 2.5E-50 Lypd6 −1.48 1.6E-06
Gm12114 7.01 3.2E-50 Slc46a1 −1.22 3.5E-06
Gm13191 8.71 4.6E-50 Hsd17b14 −1.35 5.6E-06
Tpo 7.68 4.6E-50 Csrp3 −1.21 6.7E-06
Gm16239 7.43 3.0E-49 Gm1078 −2.06 7.2E-06
Kcnk15 7.19 3.5E-49 Awat1 −1.09 1.4E-05
Chrm3 4.67 5.0E-49 Gm10228 −1.47 1.4E-05
Mecom 4.37 7.2E-49 Plin5 −1.57 1.5E-05
Gm7592 3.94 5.4E-48 Pdk4 −2.07 1.6E-05
Tie1 3.54 8.1E-48 Fam57b −1.32 1.6E-05
C86695 10.24 1.5E-46 Gfra2 −1.23 1.7E-05
Dlgap2 7.01 2.9E-46 Mybph −1.42 2.6E-05
Colgalt2 4.66 4.1E-46 Myoz2 −1.43 3.4E-05
Ush2a 7.52 2.4E-45 Fabp3 −1.13 3.4E-05
A530040E14Rik 6.04 1.0E-44 Tfr2 −1.74 3.5E-05
B3gntl1 3.71 4.4E-44 Zbtb16 −1.80 3.6E-05
Gm10653 5.36 5.3E-44 Skint10 −1.52 3.9E-05
Gm12495 8.97 5.5E-44 Mustn1 −1.18 4.5E-05
Dcc 8.26 3.8E-43 AU021092 −1.40 4.8E-05
AU019990 6.31 7.2E-42 Tspear −1.53 4.9E-05
Gm16028 10.30 3.8E-41 Krtap20-2 −1.67 5.0E-05
Arhgap8 3.83 1.3E-38 Alox15 −2.47 5.3E-05
Oas1a 5.00 2.6E-38 Krt36 −0.95 5.4E-05
AI481877 6.11 3.1E-38 Rarres1 −1.10 5.7E-05
BC026585 3.29 6.6E-38 P2ry4 −1.22 7.1E-05
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gene ontology analysis of the differentially expressed tran-
scription factors is included in Additional file 2: Table S2.
The transcription factors involved in epithelium develop-
ment are Sox2, Mecom, Lmo4, Lhx2, Six1, Six2, Twist1,
Id3, Pitx2, Tbx3, Gli2. A subset of these (Sox2, Mecom,
Lhx2, Pitx2, Tbx3 and Gli2) are also known to be involved
in brain development as are the differentially expressed
transcription factors Dlx2, Foxc1, Lef1, Gli1, Pou3f3,
Lmx1a, Six3, Lmx1b, Msx, Pitx3 and Lhx8. Abnormalities
in the abundance of these transcription factors, caused by
transcriptional dysregulation, are likely to affect the ex-
pression of their target genes. This may explain the large
number of differentially expressed genes identified in this
study.
To test if changes in transcription factor gene expres-
sion are associated with concomitant changes in the ex-
pression of their targets, we examined Lhx2, a gene
encoding a transcription factor important for epidermal
differentiation and neurogenesis [20, 21]. We found that
Lhx2 expression is decreased by 40 % in the absence of
Gtf2ird1. We used the MetaCore™ database (Thompson
Reuters) to identify genes transcriptionally regulated by
the LHX2 protein. This revealed 467 genes with known
or putative binding sites for LHX2 and which are anno-
tated as being transcriptionally regulated by Lhx2. We
found that 363 of these were expressed in at least one of
our conditions and therefore tested for differential ex-
pression. Of these, we found that 66 (18 %) are differen-
tially regulated in this study (Table 3). Of most interest are
the genes transcriptionally activated by LHX2 but which
are seen in this study to have decreased expression con-
sistent with a decrease in LHX2 such as the cluster of 10
genes involved in development (Pdlim3, Mef2c, Aldh1a2,
Ndn,Tspan12, Sopb,Thbs4,Ttn, Dact1, Lhx8).
Functional analysis of all the differentially expressed
genes using gene ontology analysis and gene set
enrichment
In order to investigate the functional associations of the
differentially expressed genes, we used the BiNGO tool
available in Cytoscape to analyse all up-regulated and
down-regulated genes for enrichment of biological pro-
cesses. We used REVIGO to visualize the results as
treemaps (Fig. 2a, b). We see different overarching func-
tional themes emerging in the up-regulated and down-
regulated genes. The up-regulated genes are highly
enriched for terms involving the cell cycle, immunity
and response to stimulus. The down-regulated genes are
highly enriched for structural development/morphogen-
esis and chemical homeostasis. The ontology terms asso-
ciated with down-regulated genes are also enriched for
signalling, ion transport/homeostasis, and cell adhesion.
Full details of the gene ontology analysis can be found in
Additional file 2: Table S2.
We carried out gene set enrichment analysis (GSEA)
using the GSEAPreranked tool to identify gene sets in-
corporating biological processes and Kegg pathways.
This produced results generally consistent with the
BiNGO analysis. RNA processing and Cell cycle pro-
cesses were associated with the up-regulated genes while
anatomical structure development and system develop-
ment were enriched in the down-regulated genes.
Enriched KEGG pathways included those involved in
RNA processing and cell cycle as well as signalling path-
ways such as immune system signalling and develop-
ment signalling pathways such as the hedgehog and Wnt
pathways. The gene sets with the highest normalized en-
richment scores (NES), are presented in Table 4, the full
GSEA results can be found in Additional file 3 :Table S3.
Signalling pathways are dysregulated in Gtf2ird1 knockout
tissue
Our gene ontology analysis and gene set enrichment
analysis points to the involvement of multiple signalling
pathways within the broad spectrum of gene dysregula-
tion reported in this study. Differentially expressed genes
involved in these signalling pathways are detailed in
Additional file 4: Table S4 (Tables S1–S7). A schematic
of the primary dysregulated signalling pathways is pre-
sented in Fig. 3. We see altered expression of growth
factors (Additional file 4: Table S1), stimulating cyto-
kines (Additional file 4: Table S2), Wnt signalling mole-
cules (Additional file 4: Table S3), calcium signalling
(Additional file 4: Table S4), cell cycle genes (Additional
file 4: Table S5), hedgehog signalling (Additional file 4:
Table S6) and G protein-coupled receptor signalling
Table 1 Top 50 up-regulated and down-regulated genes found using edgeR (Continued)
Sp140 4.27 5.1E-37 Cyp17a1 −1.82 7.7E-05
Aqp9 3.00 7.9E-37 Ankrd2 −1.49 8.1E-05
Abcb5 9.79 1.0E-36 Foxq1 −1.19 8.1E-05
Gm12724 6.50 1.7E-36 Vgll2 −1.62 8.6E-05
Defb13 7.65 1.9E-36 Gm12551 −1.16 8.8E-05
Ric3 4.41 3.2E-36 Pdlim3 −1.09 1.1E-04
aLogFC: fold change expressed as log base 2
bFDR: p value adjusted using Benjamini Hochberg method implemented in edgeR
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(Additional file 4: Table S7). Notably, we see significant
up-regulation of genes which stimulate growth factor
signalling such as Ngf (nerve growth factor) and Fgf1
(fibroblast growth factor 1) as well as genes that enhance
growth factor signalling such as Fgfbp1 (FGF-binding
protein)[22]. While Ngf, and Fgf1 have increased expres-
sion in the KO, the genes encoding their respective re-
ceptors, Ngfr and Fgfr1 have decreased expression.
We see down-regulation of members of the transform-
ing growth factor family, Tgfb2 and the bone morpho-
genetic proteins, Bmp4 and Bmp6. Stimulation of the
canonical pathway via TGFβ or the BMPs typically re-
sults in phosphorylation and activation of the SMAD
transcription factors [23]. We find no significant change
in expression of the activating SMADs. Down-regulation
of Tgfb2, which is an inhibitor of cellular proliferation, is
consistent with the other evidence of increased cell div-
ision and proliferation seen in the KO phenotype [6].
The Wnt genes, Wnt7b, Wnt10b, and Wnt11 are all
down-regulated in the KO. The most significantly down-
regulated of these is Wnt7b, which is active in the ca-
nonical Wnt pathway. This is followed by Wnt11, which
activates the non-canonical Wnt-calcium pathway that
affects cytoskeletal dynamics and cell adhesion [24, 25]
and Wnt10b, known to promote the differentiation of
skin epithelial cells and the development of hair follicles
[26]. More generally, we find that a number of genes in-
volved in calcium signalling are differentially expressed
in the KO, as listed in Additional file 4: Table S4.
Increased growth factor signalling might be expected
to result in increased cellular proliferation. We note that
several of the up-regulated genes are involved in creating
the cytoarchitecture of microtubules required for cell
division during the mitotic phase of the cell cycle. For
example, we see up-regulation of genes involved in cyto-
kinesis or spindle formation and stabilization, such as
Prc1, Anln, Aspm, Cenpe, Spdl1, Kif11, and Spag5. We
also see increased expression of genes involved in chro-
matin condensation and the correct segregation of chro-
mosomes during cell division, such as Sgol1, Smc1a,
Smc2, Smc3 and Smc4. (Additional file 4, Table S5).
Genes known to be regulated by GTF2IRD1 and other
known interaction partners of GTF2IRD1
The large number of differentially expressed genes iden-
tified in this study contrasts with the small number of
direct interaction partners of GTF2IRD1 that are cur-
rently annotated, in the MetaCore and BioGRID data-
bases (http://thebiogrid.org). The targets listed in the
MetaCore database are primarily genes thought to be
transcriptionally regulated by GTF2IRD1. The interac-
tions listed in the BioGRID database are protein targets
identified by Affinity-Capture and Two-hybrid methods.
Our search of the MetaCore database produced 16
Table 2 Differentially expressed transcription factors
Gene logFCa FDRb Gene logFCa FDRb
Ahrr 2.34 9.3E-10 Mlxipl −0.81 1.1E-02
Arntl2 1.23 1.1E-03 Msx1 −0.71 2.7E-02
Ascl2 −1.42 5.6E-03 Msx2 −0.92 3.1E-03
Bach2 −0.64 2.5E-02 Mycn −0.83 2.1E-02
Bcl3 0.92 1.5E-02 Myf6 −1.27 3.0E-03
Cited2 −0.61 3.4E-02 Myog −1.11 1.7E-02
Clock 1.18 4.1E-04 Nfe2l2 1.03 2.6E-05
Creb3l1 −0.91 2.3E-02 Nfia −0.66 1.6E-02
Dlx2 −0.77 1.9E-02 Nfic −0.81 3.4E-02
Ebf1 −0.71 2.4E-02 Nfil3 −0.68 3.2E-02
Ehf 1.22 2.3E-03 Patz1 −0.68 3.8E-02
Esrrb −1.59 2.1E-02 Pax7 −1.40 1.1E-02
Esrrg −0.79 3.1E-02 Pitx2 −0.67 2.6E-02
Fosl1 1.38 6.9E-06 Pitx3 −0.87 2.8E-02
Foxc1 −0.70 2.4E-02 Pou3f3 −1.58 5.1E-03
Foxe1 −0.94 2.5E-02 Rorc −1.26 1.1E-04
Foxl2 −1.21 2.2E-02 Scml2 1.28 7.5E-05
Foxp3 1.43 1.6E-03 Six1 −1.13 7.5E-03
Foxq1 −1.19 8.1E-05 Six2 −1.13 2.7E-02
Gli1 −0.74 4.1E-03 Six3 3.27 1.4E-09
Gli2 −0.77 6.6E-03 Smad6 −0.80 3.0E-02
Glis1 2.73 2.0E-23 Smarca5 0.77 2.2E-02
Glis2 −0.77 1.6E-02 Sox12 −0.75 2.0E-02
Hey1 −0.81 2.8E-02 Sox15 1.19 3.7E-04
Hoxc13 −0.90 9.4E-04 Sox2 −1.08 3.0E-02
Id3 −0.65 2.2E-02 Stat1 1.81 1.9E-08
Irf7 1.98 1.6E-09 Stat2 1.60 1.1E-07
Irf9 1.84 4.0E-14 Taf1 0.90 1.4E-02
Jdp2 −0.73 4.2E-02 Tbx2 −0.94 4.7E-03
Klf2 −0.84 3.0E-02 Tbx3 −0.66 2.6E-02
Klf9 −0.75 1.8E-02 Tcf7l1 −0.75 1.8E-02
Lef1 −0.98 1.5E-03 Tead2 −0.91 2.4E-03
Lhx2 −0.72 1.8E-02 Tfcp2 1.10 2.3E-05
Lhx8 −1.00 7.6E-03 Tfeb −0.75 2.0E-02
Lmo4 −0.73 7.5E-03 Trim25 1.02 2.8E-05
Lmx1a 4.33 1.4E-29 Tsc22d3 −1.19 1.6E-02
Lmx1b −1.02 2.4E-02 Twist1 −0.91 2.5E-02
Maf −0.89 7.0E-04 Zbtb16 −1.80 3.6E-05
Mafa −1.10 1.5E-02 Zfhx3 −0.74 3.0E-02
Mecom 4.37 7.2E-49
aLogFC: fold change expressed as log base 2
bFDR: p value adjusted using Benjamini Hochberg method implemented
in edgeR
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interaction partners and our search of the BioGRID
databases produced 13 interaction partners. Our search
results can be found in Additional file 5: Table S5. We
recently reported work involving an unbiased screening
strategy for interaction partners of GTF2IRD1 to rectify
this shortcoming [27]. Our study identified 38 novel
interaction partners that are mostly involved in chroma-
tin modification and transcriptional regulation as well as
proteins associated with the primary cilium [27].
We have looked at whether any of the identified
GTF2IRD1 interaction partners are differentially
expressed in this RNA-Seq study, since the genes that
encode these proteins may belong to a regulatory gene
network that is active at the transcriptional and post-
translational levels. Among the genes identified in the
MetaCore™ and BioGRID databases we find decreased
expression of two genes that have been implicated in
transcriptional activation by GTF2IRD1, Ccnd3 (Cyclin
Table 3 Downstream targets of Lhx2 found to be differentially regulated
Gene logFCa FDRb #c Gene logFCa FDRb #c
Ush2a 7.52 3.90E-46 TA Mef2c −0.66 4.10E-02 TA
0610040J01Rik 4.75 6.90E-54 TA Cd34 −0.71 1.90E-02 U
Sprr2d 3.47 2.20E-04 TA Thbs4 −0.71 3.70E-02 TA
Ceacam1 3 4.90E-27 TA Phactr1 −0.73 2.70E-02 TA
Samd12 2.56 5.90E-08 TA 6330403K07Rik −0.75 2.50E-02 TA
Tfec 2.29 6.60E-06 TA Tspan12 −0.77 1.60E-02 TA
Gucy1a3 2.02 1.70E-13 TA Loxl2 −0.79 4.40E-02 TA
Hsp90aa1 1.97 6.10E-08 TA Aldh1a2 −0.8 8.60E-03 TA
Gbp7 1.89 1.90E-07 TA Aldh1a2 −0.8 8.60E-03 TA
Il1f9 1.76 5.30E-08 TA Fbxo40 −0.82 2.68E-02 TA
Gbp2 1.71 1.70E-05 TA Htra3 −0.83 1.90E-02 TA
Robo1 1.7 2.80E-16 TI Cxcl14 −0.84 1.70E-02 TA
Iigp1 1.69 1.60E-03 TA Slc43a1 −0.84 1.70E-02 TA
Ccl2 1.51 7.10E-07 TI Dact1 −0.87 3.30E-02 TA
Fam171b 1.49 2.20E-06 TA Dysf −0.87 4.30E-03 TA
Serpinb11 1.43 3.50E-03 TA C1qtnf9 −0.89 2.80E-02 TA
Serpinb6c 1.36 8.50E-03 TA Ndn −0.89 2.70E-02 TA
Scml2 1.28 5.90E-05 TA Sobp −0.94 7.80E-03 TA
Slc7a11 1.2 6.14E-03 TA Krtap13-1 −0.95 8.00E-03 TA
Dsc1 1.19 4.30E-03 TA Krtap17-1 −0.95 3.60E-03 TA
Ifi47 1.05 4.80E-02 TA Has1 −0.96 4.40E-02 TI
Mphosph10 1.03 8.70E-03 TI Lhx8 −1 8.90E-03 TA
Esd 1.02 9.00E-05 TA Ranbp17 −1.01 4.20E-02 TA
Tdrd7 0.97 5.70E-04 TA Gnb3 −1.09 4.00E-02 TA
Parp8 0.94 1.30E-04 TI Pdlim3 −1.09 1.00E-04 TA
Itsn2 0.9 1.50E-02 TA Krtap8-1 −1.16 6.50E-03 TA
Lce1h 0.86 3.40E-02 TA Ttn −1.17 4.00E-02 TA
Casp1 0.85 4.90E-02 TA Il22ra2 −1.19 2.10E-02 TI
Cast 0.83 1.20E-02 TA Krtap16-3 −1.19 1.70E-03 TA
Fgf1 0.79 3.90E-03 TI Krtap14 −1.29 1.40E-03 TA
Lce1e 0.79 4.40E-02 TA Ankrd2 −1.49 7.50E-05 U
Plxna2 0.55 4.40E-02 TA Acsm1 −3.35 8.10E-13 TA
Cyp2d22 −0.61 3.60E-02 TA Chi3l4 −6.56 1.96E-03 TA
aLogFC: fold change expressed as log base 2
bFDR: p value adjusted using Benjamini Hochberg method implemented in edgeR
cMechanism by which Lhx2 acts on target gene, TA: Transcription activator, TI: Transcription inhibitor, U: unknown
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D3) expression is decreased by 30 % (FDR = 0.065) and
Tgfb2 (Transforming growth factor beta 2) decreased by
45 % (FDR = 0.002). Ccnd3 plays an important role in
cell cycle progression and in phosphorylation of RB1. In
addition to its interaction with RB1 and GTF2IRD1,
CCND3 also affects other transcription factors and may
have a repressive effect (for example on Runx1 [28] and
the androgen receptor [29]) or may have an activating
effect such as for Pparg [30], Rara [31] and Vdr [32].
TGFβ2 plays a role in the process that leads to the phos-
phorylation of SMAD, its translocation to the nucleus
and ultimately transcriptional activation [33].
Fig. 2 Gene ontology analysis of the up-regulated and down-regulated genes. Gene ontology analysis of the up-regulated and down-regulated genes was
conducted using BiNGO. The ontology terms and associated corrected p values were passed to REVIGO which performed summarization by removal of
redundant GO terms and was used to generate treemaps of the functional annotations associated with (a) the up-regulated and (b) the
down-regulated genes
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Table 4 GSEA analysis of biological process and Kegg pathways most highly ranked gene sets
GSEA Biological process gene set (Up-regulated genes) NESa GSEA Biological process gene set (Down-regulated genes) NESa
Rna_Processing 4.62 Anatomical Structure Development −4.05
Cell Cycle Process 4.49 System Process −3.98
Cell Cycle Go0007049 4.19 System Development −3.72
Cell Cycle Phase 4.04 Organ Development −3.69
M Phase 3.97 Multicellular Organismal Development −3.39
Mitotic Cell Cycle 3.94 Cell Cell Signaling −3.19
M Phase Of Mitotic Cel Cycle 3.81 Muscle Development −3.18
Rna Metabolic Process 3.76 Skeletal Development −3.15
Mrna Metabolic Process 3.66 Anatomical Structure Morphogenesis −3.04
Dna_Metabolic_Process 3.61 Synaptic Transmission −2.96
Mitosis 3.60 Organ Morphogenesis −2.92
Mrna Processing Go0006397 3.39 Striated Muscle Contraction Go 0006941 −2.84
Response To Dna Damage Stimulus 3.38 Ion Transport −2.75
Dna Repair 3.37 Transmission Of Nerve Impulse −2.70
Chromosome Organization And Biogenesis 3.18 Amine Metabolic Process −2.68
Ribonucleoprotein Complex Biogenesis And Assembly 3.14 Nervous System Development −2.66
Intracellular Transport 2.99 Neurological System Process −2.62
Translation 2.99 Generation Of Precursor Metabolites And Energy −2.50
Rna_Splicing 2.97 Regulation Of Growth −2.44
Nucleocytoplasmic Transport 2.96 Regulation Of Cell Growth −2.41
Nuclear Transport 2.95 Cation Transport −2.38
Response To Endogenous Stimulus 2.95 Nitrogen Compound Metabolic Process −2.36
Establishment Of Cellular Localization 2.89 Metal Ion Transport −2.29
Cell Cycle Checkpoint Go 0000075 2.89 Calcium Independent Cell Cell Adhesion −2.26
Cellular Localization 2.85 Transforming Growth Factor Beta Receptor Signaling Pathway −2.26
GSEA Kegg Pathways gene set NES GSEA Kegg Pathways gene set NES
Kegg Spliceosome 4.06 Kegg Parkinsons Disease −4.56
Kegg Ribosome 3.93 Kegg Oxidative Phosphorylation −4.28
Kegg Cytosolic Dna Sensing Pathway 3.46 Kegg Alzheimers Disease −4.07
Kegg Nod Like Receptor Signaling Pathway 3.45 Kegg Ecm Receptor Interaction −3.73
Kegg Nucleotide Excision Repair 3.07 Kegg Basal Cell Carcinoma −3.71
Kegg Rig I Like Receptor Signaling Pathway 2.85 Kegg Huntingtons Disease −3.67
Kegg T Cell Receptor Signaling Pathway 2.83 Kegg Cardiac Muscle Contraction −3.18
Kegg Cell Cycle 2.78 Kegg Melanogenesis −3.12
Kegg Proteasome 2.74 Kegg Hedgehog Signaling Pathway −3.07
Kegg Rna Degradation 2.68 Kegg Neuroactive Ligand Receptor Interaction −2.85
Kegg Toll Like Receptor Signaling Pathway 2.60 Kegg Dilated Cardiomyopathy −2.74
Kegg Aminoacyl Trna Biosynthesis 2.57 Kegg Glycosaminoglycan Biosynthesis Keratan Sulfate −2.56
Kegg Antigen Processing And Presentation 2.38 Kegg Hypertrophic Cardiomyopathy Hcm −2.36
Kegg Ubiquitin Mediated Proteolysis 2.35 Kegg Focal Adhesion −2.33
Kegg Primary Immunodeficiency 2.33 Kegg Calcium Signaling Pathway −2.28
Kegg Dna Replication 2.33 Kegg Arrhythmogenic Right Ventricular Cardiomyopathy Arvc −2.27
Kegg Non Homologous End Joining 2.28 Kegg Ppar Signaling Pathway −2.18
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Our RNA-Seq results show a significant increase in
expression in the Gtf2ird1 KO of Kpna2, Atf7ip, Parpbp
which code for proteins identified by Carmona-Mora et
al. (2015). We note that Trip11 and Alms1 are also in-
creased but at an FDR of 0.061 and 0.065 respectively. It
is interesting that each of these genes has been reported
as having an association with the cell cycle. Atf7ip en-
codes a transcriptional coactivator or corepressor in-
volved in cell cycle arrest [34, 35]. Parpbp plays a role in
chromatin modulation, DNA repair and cell cycle pro-
gression [36]. KPNA2 participates in nucleocytoplasmic
transport and is associated with the cell cycle and DNA
repair [37]. ALMS1 has a role in the cell cycle through
its involvement in formation and maintenance of cilia.
TRIP11 is involved in the microtubule network and in
transporting proteins to the ciliary membrane [38, 39].
Validation of RNA-Seq results with RTqPCR
In order to verify the RNA-Seq results, we conducted
RTqPCR analysis. CDNA was prepared from four lip tis-
sue RNA samples per genotype. Transcript levels for the
genes analysed were measured in comparison with the
housekeeping gene Hprt (hypoxanthine phosphoribosyl-
transferase 1) as an internal reference standard, using
the 2- ΔΔCT method [40]. Thirteen genes found to be dif-
ferentially expressed in the RNA-Seq analysis were
tested: Lrnn4, Sp110, Aqp9, Arhgap8, Lhx2, Stat1,
Wnt11, Fzd1, Tgfb2, Fgfbp1, Slc6a19, Myf6 and Krt2.
The genes tested are involved in different functional cat-
egories discussed in this paper, rather than being focused
on a single pathway in an attempt to provide a broad
confirmation of the RNA-Seq experiment. The results of
this analysis are presented in Fig. 4 (a–c). We observed a
Table 4 GSEA analysis of biological process and Kegg pathways most highly ranked gene sets (Continued)
Kegg Homologous Recombination 2.15 Kegg Glycosphingolipid Biosynthesis Ganglio Series −2.02
Kegg Basal Transcription Factors 2.15 Kegg Peroxisome −2.01
Kegg Pyrimidine Metabolism 2.15 Kegg Glycosphingolipid Biosynthesis Lacto And Neolacto Series −2.00
Kegg Epithelial Cell Signaling In Helicobacter Pylori Infection 2.12 Kegg Glycosaminoglycan Biosynthesis Chondroitin Sulfate −1.98
Kegg Apoptosis 2.06 Kegg Vascular Smooth Muscle Contraction −1.96
Kegg Mismatch Repair 2.01 Kegg Other Glycan Degradation −1.89
Kegg One Carbon Pool By Folate 1.88 Kegg Wnt Signaling Pathway −1.84
aNES: Normalised enrichment score calculated using the GSEApreranked tool
Fig. 3 Dysregulated signalling pathways in the absence of Gtf2ird1. Schematic diagram indicating signalling pathways with dysregulated gene
expression. Lists of differentially expressed genes appearing in the signaling pathways are included in Additional file 4: Tables S1, S3, S4, S7
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statistically significant increase in Fgfbp1, Arhgap8,
Lrnn4, Sp110 (Fig. 4a, b) and a statistically significant
decrease in Lhx2, Stat1, Fzd1, Tgfb2, Wnt11, Slc6a19,
Myf6 and Krt2 (Fig. 4c), in agreement with the RNA-Seq
analysis. Comparative expression levels were calculated
and the mean transcript level found in the wild type
samples was set at a value of 1 in order to plot all genes
on the same graph (Fig. 4a–c).
All of these genes tested, with the exception of Aqp9
which had high variation in the KO samples, were found
to be significantly differentially expressed in conformity
with our RNA-Seq results.
Discussion
In this work, we analysed the transcriptome of lip tissue
from a Gtf2ird1 knockout mouse line. This line was cre-
ated to better understand the effect of loss of the human
orthologue of this gene in WBS, which is a neurodeve-
lopmental disorder caused by the hemizygous deletion
of GTF2IRD1 and other genes within the Williams-
Beuren syndrome critical region of 7q11.23. Prior studies
point to GTF2IRD1 affecting craniofacial development,
cognition and behaviour [3, 5, 6, 8].
Using RNA-Seq, we have identified a large number of
up-regulated and down-regulated genes, revealing that
the inactivation of Gtf2ird1 has widespread effects. Our
functional analysis indicates that these changes in gene
expression may impact structural/morphological devel-
opment of tissue, cellular differentiation, cellular prolif-
eration and the immune response and that these
processes may be mediated through aberrant signalling.
Key molecular factors in development are transcription
factors, signalling molecules and cell adhesion molecules
and in this study we detect gene dysregulation in all
three categories. We note overlap between the gene
ontology terms highlighted in this study and those emer-
ging from earlier microarray studies, indicating involve-
ment of signalling, cell cycle and immune response in
WBS gene dysregulation [17, 41].
Although GTF2IRD1 is known to regulate gene tran-
scription [16, 42, 43], a relatively small number of direct
targets of GTF2IRD1 have been identified to date.
GTF2IRD1 has been shown to complex with the tran-
scriptional repressor RB1, leading to the suggestion that
it may be a general transcription factor, regulated
through its association with RB1 and involved in cell-
cycle progression [44]. RB1 controls cell cycle progres-
sion by interacting with the E2F family, preventing the
cell from progressing from G1 to S phase and by attract-
ing histone deacetylases (HDACs) to chromatin, thus
suppressing DNA synthesis. It has also been demon-
strated that GTF2IRD1 associates with HDAC3 and to a
lesser extent with HDAC1 [45]. It has been suggested
that the transcriptional activity of the GTF2I family may
be modulated by the HDAC proteins during develop-
ment, with this regulation being further refined by the
activity of PIAS2 (an E3-type small ubiquitin-like modi-
fier [SUMO] ligase) which associates with HDAC3 [45].
Interestingly, we do see a strong signature of dysregula-
tion in the cell cycle with up-regulation of many genes
involved in cell division and proliferation. This observa-
tion, in the absence of any change in Rb1 expression,
could be explained by a change in the post-translational
modification of RB1. In this study, we see a decrease in
Ccnd3 (FDR = 0.065) a gene that encodes a protein in-
volved in the phosphorylation of RB1. An alternative or
ancilliary explanation is that GTF2IRD1 may normally
assist RB1 to find or bind to its targets and that its
Fig. 4 RTqPCR validation of dysregulation in 13 genes identified by RNA-Seq analysis. Fold expression change relative to the mean expression
level of the wild type mice, which is set at 1 in all cases. Error bars represent SEM (*p value ≤0.05, ** p value ≤0.002, *** p value≤ 0.001, **** p
value≤ 0.0001). a Expression of Fgfbp1 and Arhgap8 was elevated in KO when normalized to the WT. No statistical difference was found in Aqp9.
b Lrrn4 and Sp110 were elevated in KO when normalized to the WT. c Expression of Stat1, Fzd1, Tgfb2, Wnt11, Lhx2, Slc6a19, Myf6 and Krt2 was
decreased in KO when normalized to the WT
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absence results in dysregulation of genes downstream of
RB1, observed as increased cellular proliferation.
If GTF2IRD1 plays a direct role in cell proliferation
through these mechanisms, one must ask why excess
proliferation has not been seen in other tissues of the
knockout mice where Gtf2ird1 is normally expressed.
One possible explanation is that, unlike skin, these other
sites undergo terminal differentiation and are not part of
a system that undergoes continuous renewal through the
activity of stem/progenitor cells and are therefore not in
a position to respond to the change in GTF2IRD1 status
in this way.
GTF2IRD1 has previously been associated with tran-
scriptional repression [13, 14] which predicts that the
majority of direct targets would show an increase in ex-
pression in the KO. It is noteworthy that the most statis-
tically significant differentially expressed genes identified
in this study are within the up-regulated group.
Our analysis points to dysregulation of a number of
transcription factors involved in tissue development. We
have drawn attention to one of these factors Lhx2, which
may be especially relevant to WBS as it is active in tissue
development and in neurological processes. LHX2 regu-
lates hair follicle development [46] and skin repair and
has been described as a central link in the genetic net-
works that coordinate multiple signalling pathways con-
trolling organ development and cell fate determination
[47]. LHX2 also regulates brain development [20] and is
an activator of SOBP [47] which has been observed to
have strikingly specific expression in the limbic system,
with disruption leading to abnormal cognition and intel-
lectual disability [48]. The putative effects of LHX2 seem
highly relevant to WBS. We have therefore validated
change in expression of Lhx2 with qPCR. In addition,
our RNA-Seq analysis showed corresponding expression
changes in many genes normally regulated by LHX2.
The dysregulation of genes that encode signalling
molecules, which ultimately impact on transcriptional
regulation, would also be predicted to contribute to
the large number of differentially expressed genes de-
tected in this study. This includes factors like
CCND3, which has a repressive effect on Runx1 [28]
and the androgen receptor [29] and an activating ef-
fect on Pparg [30], Rara [31], Vdr [32] and TGFβ2
through its actions in the SMAD pathway.
Histological analysis has revealed dysfunctions in cel-
lular proliferation and differentiation in the skin overly-
ing the lips in Gtf2ird1 knockout mice [6]. It is possible
that these dysfunctions stem from dysregulation of sig-
nalling pathways. We have found altered expression of
genes involved in multiple signalling pathways including
growth factor signalling, Wnt, BMP and hedgehog sig-
nalling. These pathways act in a highly coordinated man-
ner during the development of many tissues, although
the mechanisms of cross-talk are still areas of active re-
search [49–51].
Several members of the fibroblast growth factor (FGF)
family are dysregulated (Additional file 4: Table S1). The
FGFs regulate development by orchestrating mesoderm
patterning in the early embryo and then guiding organ de-
velopment by regulation of cell proliferation, differenti-
ation and survival [52]. Genes from this family are
expressed in keratinocytes throughout all layers of the epi-
dermis where they stimulate skin activity including induc-
tion of the induction of keratinocyte proliferation [22].
Members of the FGF family instigate signalling though
the canonical mitogen-activated protein (MAP) kinase
pathway, the STAT pathway, the PI3 kinase/AKT path-
way and the PLCγ pathway [53]. The MAP kinase path-
way is involved in cell growth and differentiation, the
PI3K pathway is implicated in cell survival and polarity
control and the PLCγ pathway may be necessary for cell
adhesion [54]. Therefore, the fibroblast growth factors
have a wide impact on biological activities that are of
direct relevance to the epidermal phenotype seen in the
KO [52, 54].
Fibroblast growth factor signalling also plays a critical
role in brain development. Gene inactivation studies have
shown that the receptors FGFR1 and FGFR2 are necessary
for brain development [55] and proper formation of the
medial prefrontal cortex and its connections with the lim-
bic circuits [56]. As well as seeing altered expression in
Fgf1 and Fgfr1, we also see a 46 % decrease in Fgfbp3, a
gene that has been associated with the regulation of anx-
iety [57]. It is plausible that some of the gene expression
changes seen in this study also occur when GTF2IRD1
levels are reduced in the brain, leading to dysregulation of
FGF signalling and its functions in limbic system control.
This could explain some of the behavioural abnormalities
that are characteristic of WBS.
The interplay between FGF signalling and other signal-
ling pathways is complex and will differ from tissue to
tissue. However, it is known that the signalling pathways
stimulated by the FGFs may also be stimulated by TGFβ,
BMPs (the bone morphogenetic proteins) and Wnt li-
gands [58]. In addition to changes in FGF signalling
genes, we report decreased expression of Tgfb2, BMPs
and Wnt signalling genes in the KO.
Overall, it appears that signalling through these ligands
is decreased in the absence of Gtf2ird1. We therefore sug-
gest that biological outcomes such as TGFβ-induced
epithelial-to-mesenchymal (EMT) transition and TGFβ-
induced axonal outgrowth may be affected. The TGFβ
proteins generally have an anti-proliferative effect in epi-
thelial cells as well as regulating the immune response.
Amelioration of this anti-proliferative action is consistent
with the hyperproliferation of epidermal cells seen in the
Gtf2ird1 KO phenotype [6].
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The Wnt signalling pathway is also involved in the
same key biological processes of cellular proliferation,
differentiation, adhesion and survival in a range of tis-
sues, and plays an important role in the nervous system
[49]. The Wnt proteins mediate transduction in three
major pathways, the canonical Wnt/β-catenin pathway,
the planar cell polarity pathway and the Wnt-calcium
pathway [24]. In each of these pathways, the Wnt ligand
binds to its cognate receptor, Frizzled. In this study, we
find that genes encoding four of the Frizzled receptors
(Fzd1, Fzd2, Fzd5 and Fzd9) are significantly down-
regulated in the KO. The most significantly down-
regulated Wnt gene is Wnt-7b, which is active in the ca-
nonical Wnt pathway. This is followed by Wnt-11, which
activates the non-canonical Wnt-calcium pathway that
affects cytoskeletal dynamics and cell adhesion [24, 25],
and Wnt-10b, known to promote the differentiation of
skin epithelial cells and development of hair follicles
[26]. We find decreased expression of genes in the Wnt-
calcium pathway, as well as in calcium ion homeostasis.
This is interesting as calcium signalling pathways are
known to be key in keratinocyte proliferation, migration
and differentiation [59], inflammation [60] and the ner-
vous system [61], all relevant to the WBS phenotype.
Patients with WBS display a number of cognitive and
behavioural abnormalities. In this study, we have observed
that the differentially expressed genes are enriched with
gene ontology terms relevant to neural processes. FGF sig-
nalling, Wnt signalling, and other forms of calcium signal-
ling are key in a number of neural processes including
neurogenesis, axon outgrowth and guidance, neuronal po-
larity, dendrite development, dendritic spine differenti-
ation and synapse formation and maintenance [62]. It is
interesting that the calcium regulated oxytocin receptor is
down-regulated in the KO. Dysregulation of oxytocin sig-
nalling is known to affect human behaviours involving
trust and bonding [63], which may be particularly relevant
to WBS [64].
It must be borne in mind that we have only tested lip
tissue in this study. However, it is plausible that the
mechanisms of GTF2IRD1 regulation that are disrupted
here also operate in other tissue types including the
brain. Microarray analysis of Gtf2ird1 knockout brain
tissue has so far failed to identify significant levels of
transcriptional dysregulation [15]. However, the brain is
a particularly difficult system for such investigations due
to the complexity and cellular diversity; any alterations
that occur within neuronal sub-populations are very
hard to isolate and observe. It is useful, therefore, to
generate hypotheses in proxy tissue systems, such as the
lip tissue used here, and then apply these hypotheses in
more specific ways to the brain.
In summary, we see widespread gene dysregulation in
the lip tissue of mice in which Gtf2ird1 has been
inactivated. We suggest that the loss of GTF2IRD1 has a
direct effect on the expression of some genes, as well as
altering the transcriptional control of other genes
through the disruption of downstream transcription fac-
tors and signalling pathways. The combined effect leads
to widespread gene dysregulation affecting multiple de-
velopmental mechanisms.
Conclusions
We have demonstrated that RNA-Seq is a powerful
method for investigating global transciptomic changes
resulting from Gtf2ird1 inactivation. This analysis directs
our attention to mechanisms at play in neurodevelopmen-
tal conditions such as WBS, which involves the hemizy-
gous deletion of GTF2IRD1 as well as other genes.
Overall, we see widespread changes in expression of genes
involved in tissue development and functional mainten-
ance. This is evident in the samples of epidermal tissue
analysed in this experiment but also has implications in
other tissue such as the brain. Several of the genes found
to be dysregulated play fundamental roles in a range of tis-
sues including the brain and may be highly relevant to
WBS. While the genes found to be dysregulated help to
elucidate the processes involved in WBS, we are some way
from understanding the mechanism by which GTF2IRD1
brings about these changes in gene expression. It is pos-
sible that GTF2IRD1 engages in multiple interactions with
other nuclear factors and the complexes that are formed
become located at a variety of genomic loci in order to
regulate transcription. If the primary targets of GTF2IRD1
are other transcription factors and genes involved in sig-
nalling pathways, this could account for the broad gene
dysregulation seen in this study. A clearer understanding
of GTF2IRD1 function should, therefore, emerge from
studies aimed at identifying protein-protein interactions,
transcriptomics in a variety of tissues and assays designed
to identify direct gene targets.
Methods
Animals
Gtf2ird1tm1Hrd mice, referred to as knockout (KO) mice,
were described previously [6]. The mutation has been
maintained on a C57BL/6 J background for greater than
20 generations and the experiments involved use of mice
on this background. All experimental procedures were
approved by the Animal Care and Ethics Committee at
UNSW Australia. The mice used in the RNA-Seq and
qPCR experiments were all adult females (2–6 months).
Tissue preparation
After mouse euthanasia by cervical dislocation, lip tissue
from KO and WT mice were carefully cleaned with 75 %
ethanol and DEPC-treated water. The top lip was then
dissected and immediately immersed in 2 mL of cold
Corley et al. BMC Genomics  (2016) 17:450 Page 13 of 17
TRI-reagent (Sigma). Lip tissues were homogenised until
fully dissociated (approximately 30 s) using a T10 Ultra-
Turrax homogeniser (Themo-Fisher Scientific) for sub-
sequent RNA extraction. Tail biopsies were collected to
confirm that the genotyping results established at
3 weeks old were correct.
Total RNA extraction
RNA was extracted from the dissected mouse tissues
using TRI-reagent (Sigma), following the manufac-
turer’s instructions, which included a chloroform
phase separation and ethanol precipitation. RNA was
resuspended in 70 μL of RNase-free water. RNA sam-
ples were assessed for quantity and quality using a
NanoDrop UV spectrophotometer (Thermo Fisher
Scientific Inc), conventional RNA electrophoresis and
using a Bioanalyser (Agilent Technology Inc). All
RNA integrity numbers (RIN) for the analysed sam-
ples ranged from 9 to 9.5
Transcriptome sequencing
RNA extracted from 3 WT mice and 3 KO mice was
used to prepare six mRNA libraries following the stand-
ard Illumina protocol. The six RNA-seq libraries were
sequenced on the Illumina HiSeq2000 platform at the
Ramaciotti Centre for Genomics UNSW, to produce
over 60 million, 100 nucleotide paired-end reads per
sample (Reads 1 and 2).
Mapping RNA-Seq reads
The reads were mapped to the Ensembl Mus musculus
genome (GRCm38) provided by Illumina iGenomes
(downloaded from cufflinks.cbcb.umd.edu/igenomes.html).
Mapping was performed with Tophat2 (v 2.0.8) [65] calling
Bowtie2 (v 2.1.0) [66] using the default settings.
HTSeq-count (Python package HTSeq, python v 2.7.3)
was used to generate counts of reads uniquely mapped
to annotated genes using the GRCm38 annotation gtf
file. HTSeq-count produced over 20 M uniquely aligned
reads per sample (WT1 = 27811674, WT2 = 22050557,
WT3 = 23415253, KO1 = 20164081, KO2 = 29491767,
KO3 = 22204515). 26814 genomic features were counted
with at least one read.
Differential gene expression analysis
We performed differential expression analysis using the
count based method, edgeR (v 3.8.6) [18] and we con-
firmed these results using DESeq2 (v 1.6.3) [19], both
tools are available as Bioconductor packages. Tables of
raw counts generated using HTSeq-count (described
above) were used as input in both analyses.
In the edgeR analysis, low count transcripts were
excluded and only those genes with at least 1 count
per million (cpm) in at least 3 samples were used for
analysis. A normalization factor was calculated using
the trimmed mean of M values (TMM) method [67]
and the dispersion parameter for each gene was esti-
mated using the quantile-adjusted conditional max-
imum likelihood (qCML) method, appropriated for
experiments with a single factor. The functions esti-
mateCommonDisp() and estimateTagwiseDisp() were
used to estimate dispersion. Following this we tested
for differential expression using the exact test based
on qCML methods. The Benjamini-Hochberg correc-
tion was used with a false discovery cut-off of 0.1.
DESeq2 uses a generalised linear model (GLM) to
assess differential expression. Dispersions were esti-
mated using a Cox-Reid adjusted profile likelihood
and the Wald test for significance of GLM was used.
Automatic filtering is incorporated to exclude low
abundance genes in the testing process.
Functional analysis
We used the BiNGO plug-in to Cytoscape [68] to in-
vestigate the functional associations of genes found to
be either down-regulated or up-regulated. As back-
ground we used the set of 14,526 genes used in our
differential expression analysis. Of these, 13,376 genes
were used in the gene ontology analysis. The Gene
Ontology (GO) terms in the category Biological
Process were tested for overrepresentation using the
hypergeometric test and p values were corrected using
the Benjamini & Hochberg FDR correction. Enriched
GO were selected using a corrected p value of 0.01.
We used the REVIGO tool [69] to visualize the gene
ontology terms associated with the differentially
expressed genes.
We used the GseaPrePranked tool to indentify the
enriched gene sets in c5.bp.v5.1.symbols.gmt of
MSigDB (biological process) and in c2.cp.kegg.v5.1.-
symbols.gmt of MSigDB (Kegg pathways) with a per-
mutation of 1000. An FDR q-value were of 0.05 was
adopted [70].
We used MetaCore™ from Thomson Reuters to in-
terrogate the list of differentially expressed genes for
associated transcription factor factors. This allowed us
to identify 78 transcription factors which are differen-
tially expressed. MetaCore™ comprises a suite of soft-
ware and an extensive database, which contains
manually curated information on proteins, genes,
complexes, metabolites, RNA and DNA and their in-
teractions gleaned from the published literature. We
also used MetaCore™ to find interaction partners of
genes of interest.
We used BiNGO to obtain gene ontology terms asso-
ciated with the differentially expressed transcription
factors.
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Validation with RTqPCR
Reverse transcription
First-strand cDNA synthesis was carried out using the
SuperScript® III Reverse Transcriptase (Invitrogen™),
with Random Hexamer Primer (Thermo Scientific™)
using 1 μg of total RNA as template, according to the
manufacturer’s instructions.
Quantitative real time-PCR
CDNA was prepared from four lip tissue RNA samples
per genotype (4 adult WT mice and 4 adult KO mice).
Small samples of the cDNA (1–2 % of the total) were
used as a template for quantitative PCR (qPCR) using the
Fast SYBR® Green Master Mix (Applied Biosystems™). Re-
actions were set up to a total volume of 10 μL according to
the product protocol and performed on the Stratagene
MX3005P qPCR system (Agilent Technologies). Each reac-
tion was set up in triplicate for the target gene under test.
Triplicate reactions were also set up with an identical
amount of template using primers designed against mouse
Hprt (hypoxanthine phosphoribosyltransferase 1) as a
housekeeping gene reference standard (see Additional file 6
for primer sequences).
For all RTqPCR assays, the efficiency of the different pri-
mer sets was tested by establishing a standard curve using
serial dilutions of a cDNA pool made by combining sam-
ples of all the templates used in each experiment. MxPro
QPCR Software was used to analyse the dissociation and
amplification curves of every experiment and to obtain the
threshold cycle values (Ct). Data were then analysed using
Microsoft Excel for quantitation of target gene relative to
the reference standard using the 2- ΔΔCT method [40].
T-test analyses were performed on the 2- ΔΔCT values for
the two groups of samples.
Additional files
Additional file 1: S1. Differentially expressed genes found by edgeR. This
file contains the analysis results for all genes tested by edgeR. (XLSX 1794 kb)
Additional file 2: Table S2. Gene ontology analysis performed with the
BiNGO plug-in to Cytoscape. The lists of up-regulated and down-regulated
genes were analysed for enrichment of gene ontology terms using BiNGO.
The results are presented in this file. The results of gene ontology analysis
for the DE transcription factors are also in this file. (XLSX 154 kb)
Additional file 3: Table S3. Gene set enrichment analysis using the
GSEApreranked tool. The full results of the GSEA analysis for biological
process and Kegg pathways are in this file. (XLSX 96 kb)
Additional file 4: Table S4. (Tables S1–S7) Categorisation of Subsets
of differentially expressed genes. This file includes tables of genes found to
be differentially expressed which are involved in growth factor signalling
(Table S1), cytokine signalling (Table S2), Wnt signalling (Table S3), Calcium
signalling (Table S4), Cell cycle (Table S5), Hedgehog signalling (Table S6)
and G protein-coupled signalling (Table S7). (XLSX 89 kb)
Additional file 5: Table S5. Searches for GTF2IRD1 interaction partners
in the BioGRID and MetaCore databases. (XLSX 51 kb)
Additional file 6: Table S6. Primers used in RTqPCR validation.
(XLSX 10 kb)
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